19259-15-5 Usage
Uses
Used in Pharmaceutical Industry:
3,4-Difluorothiophene is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to enhance the reactivity and properties of the resulting compounds, contributing to the development of new drugs with improved efficacy and safety profiles.
Used in Agrochemical Industry:
In the agrochemical sector, 3,4-Difluorothiophene serves as a crucial building block for the creation of novel agrochemicals, helping to improve the effectiveness of pesticides and other agricultural chemicals while potentially reducing their environmental impact.
Used in Electronic Materials Industry:
3,4-Difluorothiophene is utilized as a precursor in the production of electronic materials, such as organic light-emitting diodes (OLEDs), due to its unique electronic properties that contribute to the performance and efficiency of these devices in display technologies.
Used in Polymer Production:
3,4-Difluorothiophene is also used in the synthesis of polymers, where its reactivity and chemical properties are leveraged to create polymers with specific characteristics, such as improved thermal stability or enhanced electrical conductivity.
Overall, 3,4-Difluorothiophene plays a significant role in the synthesis of diverse compounds and materials, establishing its importance in the fields of organic chemistry and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 19259-15-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,2,5 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 19259-15:
(7*1)+(6*9)+(5*2)+(4*5)+(3*9)+(2*1)+(1*5)=125
125 % 10 = 5
So 19259-15-5 is a valid CAS Registry Number.
19259-15-5Relevant academic research and scientific papers
2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE
-
Page/Page column 215, (2021/06/26)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA compounds) that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aaRS) (e.g., bacterial leucyl-tRNA synthetase, LeuRS). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase; to treat disorders that are ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetase; to treat bacterial infections; etc.
Tetrafluorothiophene S, S-dioxide: A perfluorinated building block
Lemal, David M.,Akashi, Marc,Lou, Yan,Kumar, Vivek
, p. 12330 - 12337 (2014/01/17)
Tetrafluorothiophene S,S-dioxide, a highly reactive diene and dienophile, has been synthesized. A new route to 3,4-difluoro- and tetrafluorothiophene has been realized, and the previously unknown 2,3,4-trifluorothiophene has been obtained. The reactivity of tetrafluorothiophene S-oxide has been compared with that of the S,S-dioxide.
